ImmuCell Corp (NASDAQ:ICCC)
| 3.49 Data as of 12:07pm ET |  +0.04 / +1.16%Today’s Change | 3.25 Today|||52-Week Range 7.00 | -12.75% Year-to-Date |
Latest ICCC News | Press Releases
No recent news for ImmuCell Corp.
Today’s Trading
| Previous close | 3.45 |
| Today’s open | 3.57 |
| Day’s range | 3.48 - 3.57 |
| Volume | 2,215 |
| Average volume (3 months) | 2,549 |
| Market cap | $10.4M |
| Dividend yield | -- |
Data as of 12:07pm ET, 05/20/2013
Growth & Valuation
| Earnings growth (last year) | -- |
| Earnings growth (this year) | -- |
| Earnings growth (next 5 years) | -- |
| Revenue growth (last year) | +5.45% |
| P/E ratio | 116.3 |
| Price/Sales | 2.24 |
| Price/Book | 1.13 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| CXMCardium Therapeutics... | +0.00 | +4.90% |
| OXBTOxygen Biotherapeuti... | +0.09 | +2.05% |
| CBMXCombiMatrix Corp | -0.10 | -3.01% |
| --Premier Biomedical I... | 0.00 | 0.00% |
Data as of 3:24pm ET, 05/20/2013
Financials
| Last reporting date | -- |
| EPS forecast (this quarter) | -- |
| Annual revenue (last year) | $5.4M |
| Annual profit (last year) | $89.5K |
| Net profit margin | 1.66% |
Profile
Sector Health Technology |
Industry Medical Specialties |
Chairman, Chief Scientific Officer & VP Joseph H. Crabb, PhD |
President, CEO, CFO, Secretary & Treasurer Michael F. Brigham, MBA |
Corporate headquarters Portland, Maine |
Forecasts
